This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Kosea S Frederick: Innovator in Pharmaceutical Chemistry
Introduction
Kosea S Frederick is a notable inventor based in Naugatuck, Connecticut. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on aldosterone synthase inhibitors. His research focuses on developing compounds that can be used in the treatment of various diseases and disorders.
Latest Patents
Kosea S Frederick holds a patent for aldosterone synthase inhibitors. The present invention relates to compounds of formula I and pharmaceutically acceptable salts thereof, wherein Cy, Rand Rare as defined herein. The invention also encompasses pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, and processes for preparing these compounds and intermediates useful in these processes. He has 1 patent to his name.
Career Highlights
Kosea S Frederick is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has allowed him to further his research and development efforts in the pharmaceutical sector.
Collaborations
Throughout his career, Kosea has collaborated with several talented individuals, including Daniel Richard Marshall and Bryan Patrick McKibben. These collaborations have contributed to the advancement of his research and the successful development of innovative pharmaceutical solutions.
Conclusion
Kosea S Frederick is a dedicated inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. His innovative approach and collaboration with other professionals in the field highlight his commitment to advancing medical science.